RHABDOMYOLYSE AIGUE LORS D'UNE INTOXICATION PAR MORPHINOMIMETIQUESCUVILLIER P; GOMEZ J; DUPONT T et al.1982; NOUVELLE PRESSE MEDICALE; ISSN 0301-1518; FRA; DA. 1982; VOL. 11; NO 31; PP. 2355-2356; BIBL. 3 REF.Article

COUNTING THE COSTS OF CANCER THERAPY = FAIRE LE COMPTE DU PRIX DU TRAITEMENT DU CANCERFRIEDLANDER ML; TATTERSALL MHN.1982; EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY; ISSN 0277-5379; GBR; DA. 1982; VOL. 18; NO 12; PP. 1237-1241; ABS. ENG; BIBL. 13 REF.; GRAPHArticle

CHIMIOTHERAPIE ANTICANCEREUSE PROPHYLACTIQUE ET DE COMPLEMENTFIERE D.1981; REV. PRAT.; ISSN 0035-2640; FRA; DA. 1981; VOL. 31; NO 43; PP. 3021-3040; 12 P.; ABS. ENG; BIBL. 35 REF.Article

ANTIVIRAL AGENTS AS ADJUVENTS IN CANCER CHEMOTHERAPYSHANNON VM; SCHABEL FM JR.1980; PHARMACOL. THER.; ISSN 0163-7258; USA; DA. 1980; VOL. 11; NO 2; PP. 263-390; BIBL. 37 P.Article

GEGENWAERTIGER STAND DER ADJUVANTEN CHEMOTHERAPIE MALIGNER SOLIDER TUMOREN = ETAT ACTUEL DE LA CHIMIOTHERAPIE ADJUVANTE DES TUMEURS MALIGNES SOLIDESWILMANNS W; SAUER H.1978; CHIRURG; DEU; DA. 1978; VOL. 49; NO 9; PP. 551-555; BIBL. 18 REF.Article

ADJUVANT CHEMOTHERAPY OF LARGE BOWEL CANCERGILBERT JM.1982; CANCER TREATMENT REVIEWS; ISSN 0305-7372; GBR; DA. 1982; VOL. 9; NO 3; PP. 195-228; BIBL. 138 REF.Article

LA THERAPIE ADJUVANTE DU CANCER DU SEIN: OU EN SOMMES-NOUS.DROLET Y.1983; UNION MEDICALE DU CANADA; ISSN 0041-6959; CAN; DA. 1983; VOL. 112; NO 5; PP. 429-432; ABS. ENG; BIBL. 14 REF.Article

LEVAMISOLE AS AN ADJUVANT TO CHEMOTHERAPY IN EXTENSIVE BRONCHOGENIC CARCINOMA. A VETERANS ADMINISTRATION LUNG CANCER GROUP STUDYDAVIS S; MIETLOWSKI W; ROHNWEDDER JJ et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 4; PP. 646-651; BIBL. 26 REF.Article

SUPPORTIVE CAREGREEN MR; MENDELSOHN J.1982; CANCER CHEMOTHERAPY; ISSN 505242; NLD; DA. 1982; NO 4; PP. 422-431; BIBL. 43 REF.Article

ADJUVANT CHEMOTHERAPY IN HEAD AND NECK CARCINOMACACHIN Y.1982; CLIN. OTOLARYNGOL. ALLIED SCI.; ISSN 0307-7772; GBR; DA. 1982; VOL. 7; NO 2; PP. 121-132; BIBL. 17 REF.Article

ADJUVANT THERAPIES AND MARKERS OF POST-SURGICAL MINIMAL RESIDUAL DISEASE. I. MARKERS AND GENERAL PROBLEMS OF CANCER ADJUVANT THERAPIES1979; RECENT RESULTS CANCER RES.; DEU; DA. 1979; NO 67; XVIII-150 P.; BIBL. DISSEM.Conference Paper

LA CHIMIOTHERAPIE DES CANCERS DIGESTIFS; PRINCIPES GENERAUX.CHEVREL JP.1978; NOUV. PRESSE MED.; FRA; DA. 1978; VOL. 7; NO 41; PP. 3749-3752; ABS. ENG; BIBL. 30 REF.Article

NUTZEN UND GEFAHREN DER ADJUVANTEN CHEMOTHERAPIE UND BESTRAHLUNG ZUR METASTASENPROPHYLAXE = UTILITE ET DANGERS DE LA CHIMIOTHERAPIE ET DE LA RADIOTHERAPIE ADJUVANTE POUR LA PREVENTION DES METASTASESBRUNNER KW.1981; INTERNIST (BERL.); ISSN 0020-9554; DEU; DA. 1981; VOL. 22; NO 2; PP. 62-67; BIBL. 23 REF.Article

ADJUVANTE TUMORCHEMOTHERAPIE IM GESAMTKONZEPT DER KLINISCHEN ONKOLOGIE = LA CHIMIOTHERAPIE ADJUVANTE DANS LA CONCEPTION GLOBALE DE L'ONCOLOGIE CLINIQUETANNEBERGER S.1980; ARCH. GESCHW.-FORSCH.; DDR; DA. 1980; VOL. 50; NO 2; PP. 160-164; ABS. ENG; BIBL. 14 REF.Article

SURGERY PLUS ADJUVANT CHEMOTHERAPY. A REVIEW OF THERAPEUTIC IMPLICATIONS. I: BREAST CANCERCARTER SK.1980; CANCER CHEMOTHER. PHARMACOL.; DEU; DA. 1980; VOL. 4; NO 3; PP. 147-163; BIBL. 35 REF.Article

ADJUVANTE ZYTOSTATISCHE CHEMIOTHERAPIE. ZYTOSTATISCHE THERAPIE ALS REZIDIV-PROPHYLAXE. = CHIMIOTHERAPIE CYTOSTATIQUE ADJUVANTE. TRAITEMENT CYTOSTATIQUE COMME PROPHYLAXIE DES RECIDIVES.1978; HAEMATOL. U. BLUTTRANSFUS.; DEU; DA. 1978; VOL. 22; 239 P.; BIBL. DISSEM.Conference Paper

Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: A phase II studyTOPUZ, Erkan; BASARAN, Mert; SAIP, Pinar et al.American journal of clinical oncology. 2002, Vol 25, Num 6, pp 619-624, issn 0277-3732, 6 p.Article

CARCINOMA OF THE ANAL CANALBOHE M; LINDSTROEM C; EKELUND G et al.1982; SCAND. J. GASTROENTEROL.; ISSN 0036-5521; NOR; DA. 1982; VOL. 17; NO 6; PP. 795-800; BIBL. 21 REF.Article

FAVORABLE FACTORS IN THE ADJUVANT THERAPY OF BREAST CANCERCARPENTER JT JR; MADDOX WA; LAWS HL et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 1; PP. 18-23; BIBL. 21 REF.Article

ADJUVANT ORAL RAZOXANE (ICRF-159) IN RESECTABLE COLORECTAL CANCERGILBERT JM; HELLMANN K; EVANS M et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 8; NO 3; PP. 293-299; BIBL. 25 REF.Article

THE CASE FOR ADJUVANT CMF CHEMOTHERAPY IN BREAST CANCER. HAS IT BEEN MADE.LEVITT SH; POTISH RA.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 4; PP. 363-369; BIBL. 14 REF.Article

COMPARISON OF TAMOXIFEN AND HYPOPHYSECTOMY IN BREAST CANCER TREATMENTKIANG TD; FRENNING DH; VOSIKA GJ et al.1980; CANCER; USA; DA. 1980; VOL. 45; NO 6; PP. 1322-1325; BIBL. 9 REF.Article

SOFT-TISSUE SARCOMAS IN THE YOUNG: MEDICAL TREATMENT ADVANCES IN PERSPECTIVEJENKIN D; SONLEY M.1980; CANCER; ISSN 0008-543X; USA; DA. 1980; VOL. 46; NO 3; PP. 621-629; BIBL. 22 REF.Article

A STUDY OF RELAPSE AND COURSE OF 153 CASES OF HODGKIN'S DISEASE (CLINICAL STAGES I AND II) TREATED AT THE INSTITUTE GUSTAVE-ROUSSY FROM 1963 TO 1970 WITH RADIOTHERAPY ALONE OR WITH ADJUVANT MONOCHEMOTHERAPYPENE F; HENRY AMAR M; LEBOURGEOIS JP et al.1980; CANCER; ISSN 0008-543X; USA; DA. 1980; VOL. 46; NO 10; PP. 2131-2141; BIBL. 31 REF.Article

ACUTE IRON POISONING: A REVIEWROBOTHAM JL; LIETMAN PS.1980; AM. J. DIS. CHILD. (1960); ISSN 0002-922X; USA; DA. 1980; VOL. 134; NO 9; PP. 875-879; BIBL. 69 REF.Article